These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30633430)

  • 21. No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study.
    Stenbæk DS; Dam VH; Fisher PM; Hansen N; Hjordt LV; Frokjaer VG
    PLoS One; 2017; 12(9):e0184403. PubMed ID: 28880910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study.
    Moresco FM; Dieci M; Vita A; Messa C; Gobbo C; Galli L; Rizzo G; Panzacchi A; De Peri L; Invernizzi G; Fazio F
    Neuroimage; 2002 Nov; 17(3):1470-8. PubMed ID: 12414286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.
    Ettrup A; Holm S; Hansen M; Wasim M; Santini MA; Palner M; Madsen J; Svarer C; Kristensen JL; Knudsen GM
    Mol Imaging Biol; 2013 Aug; 15(4):376-83. PubMed ID: 23306971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT
    Edgar FG; Hansen HD; Leth-Petersen S; Ettrup A; Kristensen JL; Knudsen GM; Herth MM
    J Labelled Comp Radiopharm; 2017 Oct; 60(12):586-591. PubMed ID: 28856700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ITI-007 demonstrates brain occupancy at serotonin 5-HT₂A and dopamine D₂ receptors and serotonin transporters using positron emission tomography in healthy volunteers.
    Davis RE; Vanover KE; Zhou Y; Brašić JR; Guevara M; Bisuna B; Ye W; Raymont V; Willis W; Kumar A; Gapasin L; Goldwater DR; Mates S; Wong DF
    Psychopharmacology (Berl); 2015 Aug; 232(15):2863-72. PubMed ID: 25843749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral 5-HT release correlates with [
    Jørgensen LM; Weikop P; Villadsen J; Visnapuu T; Ettrup A; Hansen HD; Baandrup AO; Andersen FL; Bjarkam CR; Thomsen C; Jespersen B; Knudsen GM
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):425-434. PubMed ID: 26825776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
    Meyer PT; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM; Hinz R
    Neuroimage; 2010 Apr; 50(3):984-93. PubMed ID: 20083209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study.
    Marner L; Frokjaer VG; Kalbitzer J; Lehel S; Madsen K; Baaré WF; Knudsen GM; Hasselbalch SG
    Neurobiol Aging; 2012 Mar; 33(3):479-87. PubMed ID: 20510480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.
    Rosell DR; Thompson JL; Slifstein M; Xu X; Frankle WG; New AS; Goodman M; Weinstein SR; Laruelle M; Abi-Dargham A; Siever LJ
    Biol Psychiatry; 2010 Jun; 67(12):1154-62. PubMed ID: 20434136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep deprivation increases cerebral serotonin 2A receptor binding in humans.
    Elmenhorst D; Kroll T; Matusch A; Bauer A
    Sleep; 2012 Dec; 35(12):1615-23. PubMed ID: 23204604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of changes in endogenous serotonin level by positron emission tomography with [
    Ikoma Y; Takuwa H; Nishino A; Maeda J; Kawamura K; Obata T; Zhang MR; Higuchi M; Suhara T
    Ann Nucl Med; 2021 Aug; 35(8):955-965. PubMed ID: 34101154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.